NCT02642471View on ClinicalTrials.gov

Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)

NAActive, not recruitingINTERVENTIONAL

Enrollment

1,080

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Cervical CancerSurgeryQuality of Life

Interventions

PROCEDURE

no systematic pelvic lymphadenectomy

systematic pelvic lymphadenectomy is omitted in surgical treatment

Trial Locations (1)

510060

Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT02642471 - Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010) | Biotech Hunter | Biotech Hunter